Tempest Therapeutics, Inc. (TPST)
NASDAQ: TPST · Real-Time Price · USD
2.280
-0.010 (-0.44%)
At close: Feb 27, 2026, 4:00 PM EST
2.200
-0.080 (-3.51%)
After-hours: Feb 27, 2026, 7:54 PM EST
Tempest Therapeutics Market Cap
Tempest Therapeutics has a market cap or net worth of $30.74 million as of February 27, 2026. Its market cap has decreased by -21.61% in one year.
Market Cap
30.74M
Enterprise Value
31.63M
1-Year Change
-21.61%
Ranking
Category
Stock Price
$2.28
Market Cap Chart
Since June 28, 2021, Tempest Therapeutics's market cap has decreased from $88.65M to $30.74M, a decrease of -65.33%. That is a compound annual growth rate of -20.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 27, 2026 | 30.74M | 117.36% |
| Dec 31, 2025 | 14.14M | -61.17% |
| Dec 31, 2024 | 36.42M | -57.00% |
| Dec 29, 2023 | 84.69M | 600.22% |
| Dec 30, 2022 | 12.09M | -66.85% |
| Dec 31, 2021 | 36.49M | -58.84% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RenovoRx | 32.98M |
| Lantern Pharma | 32.77M |
| ABVC BioPharma | 32.47M |
| Rallybio | 31.42M |
| Werewolf Therapeutics | 31.25M |
| Dyadic International | 30.04M |
| Passage Bio | 29.40M |
| NeuroSense Therapeutics | 29.39M |